About Ascribe Bioscience
Ascribe Bioscience is a company based in Ithaca (United States) founded in 2017 by Murli Manohar. Ascribe Bioscience has raised $17.68 million across 9 funding rounds from investors including Corteva Agriscience, HHS and The Yield Lab. Ascribe Bioscience offers products and services including Phytalix. Ascribe Bioscience operates in a competitive market with competitors including Ginkgo Bioworks, AgBiome, Pluton Biosciences, AgroSpheres and Boost Biomes, among others.
- Headquarter Ithaca, United States
- Founders Murli Manohar
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ascribe Bioscience Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.68 M (USD)
in 9 rounds
-
Latest Funding Round
$12 M (USD), Series A
Oct 14, 2025
-
Investors
Corteva Agriscience
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ascribe Bioscience
Ascribe Bioscience offers a comprehensive portfolio of products and services, including Phytalix.
Natural product that protects crops from fungal and bacterial pathogens using soil molecules.
People of Ascribe Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Ascribe Bioscience
Ascribe Bioscience has successfully raised a total of $17.68M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ascribe Bioscience
Ascribe Bioscience has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Corteva Agriscience, HHS and The Yield Lab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A privately owned industrial group focused on chemical investments.
|
Locked | Locked | Locked | |
|
Venture capital firm & accelerator focused on early-stage companies
|
Locked | Locked | Locked | |
|
Early & late stage life sciences & tech focused VC firm investing primarily in the US
|
Locked | Locked | Locked |
Investor details for Ascribe Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ascribe Bioscience
Investment portfolio details for Ascribe Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ascribe Bioscience
Detailed financials for Ascribe Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ascribe Bioscience Comparisons
Peer comparison for Ascribe Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ascribe Bioscience
Ascribe Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ginkgo Bioworks, AgBiome, Pluton Biosciences, AgroSpheres and Boost Biomes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Provider of microbe-based crop protection solutions
|
|
| Locked | Locked | Locked |
Assay-based microbial research services are offered for industrial applications.
|
|
| Locked | Locked | Locked |
Manufacturer and supplier of biological agrochemicals
|
|
| Locked | Locked | Locked |
Microbiome-based products for crop protection are developed using DNA sequencing.
|
Detailed competitors of Ascribe Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ascribe Bioscience
Complete news archive for Ascribe Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ascribe Bioscience
Ascribe Bioscience was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Ascribe Bioscience is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Ascribe Bioscience is a funded company, having raised a total of $17.68M across 9 funding rounds to date.
Ascribe Bioscience was founded in 2017 in Ithaca, United States, within the agricultural biotechnology sector. Microbe-based biological inputs for crops are developed, focusing on natural biopesticides. Plant immunity is enhanced, and pathogens such as fungi, bacteria, nematodes, and viruses are targeted across various crops. Applications include seed treatments, foliar sprays, and soil additives to support crop protection operations.
Ascribe Bioscience's top competitors include Ginkgo Bioworks, AgroSpheres and Switch Bioworks.
Ascribe Bioscience offers Phytalix.
Ascribe Bioscience has 10 investors. Key investors include Corteva Agriscience, HHS, The Yield Lab, International Chemical Investors, and Source Agriculture.